Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors

Share this content:
Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors
Resistance Training Improves Posttreatment Outcomes for Breast Cancer Survivors

Survivors of breast cancer often suffer in multiple ways from their disease, its treatment, and the side effects of both. An especially cruel consequence is the adverse effects that have the potential to further change a woman's body, leading to chronic pain, disability, and even death. 

The altered body composition and decreased bone mineral density (BMD) that follows cancer may result in osteopenia and osteoporosis. The greater potential for hip and vertebral fractures bring an increased risk of mortality. New research is finding that resistance training may help. 

Impact of Cancer Treatment on BMD

In a multicenter review of the effects of resistance training in breast cancer, researchers focused on its potential for maintaining bone density.1 Bone mineral density, they noted, is at risk from a number of assaults. For example, chemotherapy adversely affects the size of the osteoids, which reduces bone formation and bone density. 

Chemotherapy also results in permanent ovarian failure, which has an adverse effect on bone formation as well. And, aromatase inhibitors (AIs) deplete estrogen production. Bone density measurements obtained from the hip and spine of postmenopausal patients with breast cancer revealed a significantly greater loss of bone density in these patients compared with breast cancer patients who did not receive adjuvant chemotherapy.

Up to 80% of women with breast cancer experience bone loss caused by their cancer treatment. Bone loss occurs much quicker in women with breast cancer compared with those without breast cancer. Similarly, among women with osteoporosis, those with cancer have a higher rate of falls and their risk of fractures is 5 times higher compared with those who do not have cancer.1  

Page 1 of 3
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs